Rockstroh JK - Search Results

1

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.

Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Cahn P, et al. Among authors: rockstroh jk. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420123 Clinical Trial.

2

Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study Group.

Rockstroh JK, Bergmann F, Wiesel W, Rieke A, Thiesen A, Fätkenheuer G, Oette M, Carls H, Fenske S, Nadler M, Knechten H. Rockstroh JK, et al. AIDS. 2000 Jun 16;14(9):1181-5. doi: 10.1097/00002030-200006160-00015. AIDS. 2000. PMID: 10894282 Clinical Trial.

3

Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.

Wasmuth JC, Herhaus C, Römer K, Salzberger B, Kaiser R, Schliefer K, Voigt E, Rockstroh JK. Wasmuth JC, et al. Among authors: rockstroh jk. AIDS. 2002 May 3;16(7):1077-8. doi: 10.1097/00002030-200205030-00018. AIDS. 2002. PMID: 11953478 No abstract available.

4

Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients.

Rockstroh JK, Mudar M, Lichterfeld M, Nischalke HD, Klausen G, Gölz J, Dupke S, Notheis G, Stein L, Mauss S; German Clinical AIDS Working group (KAAD). Rockstroh JK, et al. AIDS. 2002 Oct 18;16(15):2083-5. doi: 10.1097/00002030-200210180-00016. AIDS. 2002. PMID: 12370510

5

First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results.

Voigt E, Wickesberg A, Wasmuth JC, Gute P, Locher L, Salzberger B, Wöhrmann A, Adam A, Weitner L, Rockstroh JK. Voigt E, et al. Among authors: rockstroh jk. HIV Med. 2002 Oct;3(4):277-82. doi: 10.1046/j.1468-1293.2002.00123.x. HIV Med. 2002. PMID: 12444946 Free article. Clinical Trial.

6

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.

Qurishi N, Kreuzberg C, Lüchters G, Effenberger W, Kupfer B, Sauerbruch T, Rockstroh JK, Spengler U. Qurishi N, et al. Among authors: rockstroh jk. Lancet. 2003 Nov 22;362(9397):1708-13. doi: 10.1016/S0140-6736(03)14844-1. Lancet. 2003. PMID: 14643119

7

Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.

Schildgen O, Schewe CK, Vogel M, Däumer M, Kaiser R, Weitner L, Matz B, Rockstroh JK. Schildgen O, et al. Among authors: rockstroh jk. AIDS. 2004 Nov 19;18(17):2325-7. doi: 10.1097/00002030-200411190-00014. AIDS. 2004. PMID: 15577546

8

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group; Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD. D:A:D Study Group, et al. Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Lancet. 2008. PMID: 18387667 Free PMC article.

9

Introduction to late presentation for HIV treatment in Europe.

Antinori A, Johnson M, Moreno S, Rockstroh JK, Yazdanpanah Y. Antinori A, et al. Among authors: rockstroh jk. Antivir Ther. 2010;15 Suppl 1:1-2. doi: 10.3851/IMP1521. Antivir Ther. 2010. PMID: 20442454

10

Management of late-presenting patients with HIV infection.

Rockstroh JK, Gatell J, Landman R, Antinori A. Rockstroh JK, et al. Antivir Ther. 2010;15 Suppl 1:25-30. doi: 10.3851/IMP1527. Antivir Ther. 2010. PMID: 20442458 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters